Answer
Venclyxto (venetoclax) is indicated for adults with newly diagnosed acute myeloid leukaemia who are ineligible for intensive chemotherapy, in combination with a hypomethylating agent or low-dose cytarabine.
Sources for this answer
- Venclyxto 10mg film-coated tabletsAbbVie Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 25Document updated
Sources checked